Effect of Mipomersen on LDL-Cholesterol Levels in Patients Treated by Regular Apheresis

NCT01598948 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Atherosclerosis
LDL-hypercholesterolemia

Interventions

DRUG: mipomersen

Sponsor

Ludwig-Maximilians - University of Munich